In coronary artery disease (CAD), an alternative way of improvement of blood circulation in the ischemic area of the myocardium is coronary collateral circulation. Our study aimed to investigate the rheological parameters of blood and nitric oxide (NO) content in patients with various degrees of collateral development and the likelihood of the influence of blood fluidity on collateral angiogenesis.
METHODS:
We studied patients with stable CAD who underwent elective coronary angiography and a control group with the same mean age. We investigated patients with different degrees of developing collaterals and those without them. In studied patients, the blood plasma viscosity, aggregability, and deformability of erythrocytes, as the main indicators of blood rheology. We recorded content of stable metabolic end products of nitric oxide (NOx).
RESULTS:
Results of the studies showed that in the blood of studied patients with CAD erythrocyte aggregation was increased and NO content decreased compared to the control level; NO content was as lower, as less was the number of developed collaterals was recorded.
CONCLUSION:
In this work, the role of the aggregation ability of erythrocytes and the endothelial origin of NO in the direct and feedback regulatory mechanism of angiogenesis in patients with CAD are discussed.
de MarchiSF, GloeklerS, MeierP, TraupeT, SteckH, CookS, VogelR, SeilerC. Determinants of preformed collateral vessels in the human heart without coronary artery disease, Cardiology. 2011;118(3):198–206. doi: 10.1159/000328648.
2.
GaoS, DengY, WuJ, ZhangL, DengF, ZhouJ, YuanZ, WangL. Eosinophils count in peripheral circulation is associated with coronary artery disease, Atherosclerosis. 2019;286:128–134. doi: 10.1016/j.atherosclerosis.2019.05.027.
3.
MeierP, AntonovJ, ZbindenR, KuhnA, ZbindenS, GloeklerS, DelorenziM, JaggiR, SeilerC. Non-invasive gene-expression-based detection of well-developed collateral function in individuals with and without coronary artery disease, Heart. 2009;95(11):900–8. doi: 10.1136/hrt.2008.145383.
4.
SchaperW. Collateral circulation: past and present, Basic Res Cardiol. 2009;104(1):5–21. doi: 10.1007/s00395-008-0760-x.
5.
AlsanjariO, ChouariT, WilliamsT, MyatA, SambuN, BlowsL, CockburnJ, de BelderA, Hildick-SmithD. Angiographically visible coronary artery collateral circulation improves prognosis in patients presenting with acute ST segment-elevation myocardial infarction, Catheter Cardiovasc Interv. 2020;96(3):528–533. doi: 10.1002/ccd.28532.
6.
FujitaM, NakaeI, KiharaY, HasegawaK, NoharaR, UedaK, TamakiS, OtsukaK, SasayamaS. Determinants of collateral development in patients with acute myocardial infarction, Clin Cardiol.595-9. 1999;22(9):595–9. doi: 10.1002/clc.4960220911.
7.
FaberJE, DaiX, LucittiJ. Genetic and environmental mechanisms controlling formation and maintenance of the native collateral circulation, Arteriogenesis-Molecular Regulation, Pathophysiology and Therapeutics. Aachen: Shaker Verlag. 2011)1–22.
8.
KantariaM, BuleishviliM, KipianiNV, OrmotsadzeG, SanikidzeT. RISK-FACTORS OF CORONARY ARTERY DISEASE (REVIEW), Georgian Med News. 2020; (299):78–82.
9.
StarostinIV, TalitskiiKA, BulkinaOS, ParfenovaEV, KarpovIuA. [Collateral blood flow in the myocardium: the role ofendothelial growth factor], Kardiologiia. 2012;52(11):49–55 (inRussian).
MadjidM, AwanI, WillersonJT, CasscellsSW. Leukocyte count and coronary heart disease: implications for risk assessment, J Am Coll Cardiol. 2010;44(10):1945–56. doi: 10.1016/j.jacc.2004.07.056.
12.
WangS, ZhangH, DaiX, SealockR, FaberJE. Genetic architecture underlying variation in extent and remodeling of the collateral circulation, Circ Res. 2010;107(4):558–568. doi: 10.1161/CIRCRESAHA.110.224634.
13.
ChigogidzeM, SharashidzeN, PagavaZ, TaboridzeI. The correlation of collateral circulation and age during acute ischemic heart disease, European Scientific Journal, ESJ. 2020;16(18):335. doi: org10.19044/esj.2020.v16n18p335.
14.
McHedlishviliG, MaedaN. Blood flow structure related to red cell flow: determinant of blood fluidity in narrow microvessels, Jpn J Physiol. 2001;51(1):19–30. doi: 10.2170/jjphysiol.51.19PMID: 11281993.
15.
de MarchiSF. Determinants of human coronary collaterals, Curr Cardiol Rev. 2014;10(1):24–8. doi: 10.2174/1573403x1001140317114411.
16.
MarkovKhM. Nitrogen oxide and the cardiovascular system, Usp Fiziol Nauk. 2001;32(3):49–65 (in Russian).
17.
IgnarroLJ, CirinoG, CasiniA, NapoliC. Nitric oxide as a signaling molecule in the vascular system: an overview, J Cardiovasc Pharmacol. 1999;34(6):879–86. doi: 10.1097/00005344-199912000-00016.
18.
FeilR, LohmannSM, de JongeH, WalterU, HofmannF. Cyclic GMP-dependent protein kinases and the cardiovascular system: insights from genetically modified mice, Circ Res. 2003;93(10):907–16. doi: 10.1161/01.RES.0000100390.68771.CC.
19.
ChernukhAM, AleksandrovPM, AlekseevOV Microcirculation. ed. Moskow: Meditsina; 1984. (in Russian).
20.
KirichukVF, OsipovaOV, NikitinaNM Defect of a blood flow property and its revealing in ischemic states. Rotational viscosimetry. ed. Saratov Publishing House: Sarat.Med.Un-ta; 1998. (in Russian).
21.
LevtovVA, RegirerSA, ShadrinaNKh Rheology of the blood. ed. Moskow: Meditsina; 1982. (in Russian).
22.
AzizovaOA, AseichevAV, PiryazevAP, RoitmanEV, ShcheglovitovaON. Effects of oxidized fibrinogen on the functions of blood cells, blood clotting, and rheology, Bull Exp Biol Med. 2007;144(3):397–407. doi: 10.1007/s10517-007-0341-2.
23.
JubelinBC, GiermanJL. Erythrocytes may synthesize their own nitric oxide, Am J Hypertens. 1996;9(12 Pt 1):1214–9. doi: 10.1016/S0895-7061(96)00257-9.
24.
KollerA, SchlossmannJ, AshmanK, Uttenweiler-JosephS, RuthP, HofmannF. Association of phospholamban with a cGMP kinase signaling complex, Biochem Biophys Res Commun. 2003;300(1):155–60. doi: 10.1016/s0006-291x(02)02799-7.
25.
RentropKP, CohenM, BlankeH, PhillipsRA. Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects, J Am Coll Cardiol. 1985;5(3):587–92. doi: 10.1016/s0735-1097(85)80380-6.
26.
CronsteinBN, WeissmannG. The adhesion molecules of inflammation, Arthritis Rheum. 1993;36(2):147–57. doi: 10.1002/art.1780360204.
27.
McHedlishviliG. Basic factors determining the hemorheological disorders in the microcirculation, Clin Hemorheol Microcirc. 200430(3-4):179–80.
28.
MantskavaM, MomtselidzeN, PargalavaD. Rheological status (erythrocyte aggregation index, erythrocyte deformation index, plasma viscosity) in the Covid-19 patients with “Covid toes” and in patients with Raynaud’s phenomenon, Series on Biomechanics. 2022;36(1):75–79. doi: 10.7546/SB.10.2022.
29.
LeblondPF, CoulombeL. Evaluation of a simplified filtration technique for the routine measurement of erythrocyte deformability, Scand J Clin Lab Invest Suppl. 1981;156:35–40. doi: 10.3109/00365518109097427.
30.
AbelEW, WielogorskiJW. A clinical capillary blood viscometer, J Med Eng Technol. 1977;1(1):42–4. doi: 10.3109/03091907709161587.
31.
MirandaKM, EspeyMG, WinkDA. A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite, Nitric Oxide. 2001;5(1): 62–71. doi: 10.1006/niox.2000.0319.
32.
ChkhitauriL, SanikidzeT, GiorgadzeE, AsatianiK, KipianiN, MomtselidzeN, MantskavaM. Comprehensive study of the rheological status and intensity of oxidative stress during the progression of type 2 diabetes mellitus to prevent its complications, Clin Hemorheol Microcirc. 2023;83(1):69–79. doi: 10.3233/CH-221512.
33.
KimEK, ChoiJH, SongYB, HahnJY, ChangSA, ParkSJ, LeeSC, ChoiSH, ChoeYH, ParkSW, GwonHC. A protective role of early collateral blood flow in patients with ST-segment elevation myocardial infarction, Am Heart J. 2016;171(1):56–63. doi: 10.1016/j.ahj.2015.10.016.
34.
AntoniucciD, ValentiR, MoschiG, MiglioriniA, TrapaniM, SantoroGM, BologneseL, CerisanoG, BuonamiciP, DovelliniEV. Relation between preintervention angiographic evidence of coronary collateral circulation and clinical and angiographic outcomes after primary angioplasty or stenting for acute myocardial infarction, Am J Cardiol. 2002;89(2):121–5. doi: 10.1016/s0002-9149(01)02186-5.
35.
MeierP, HemingwayH, LanskyAJ, KnappG, PittB, SeilerC. The impact of the coronary collateral circulation on mortality: a meta-analysis, Eur Heart J. 2012;33(5):614–21. doi: 10.1093/eurheartj/ehr308.
36.
de MarchiSF. Determinants of human coronary collaterals, Curr Cardiol Rev. 2014;10(1):24–8. doi: 10.2174/1573403x1001140317114411.
37.
DaiX, FaberJE. Endothelial nitric oxide synthase deficiency causes collateral vessel rarefaction and impairs activation of a cell cycle gene network during arteriogenesis, Circ Res. 2010;106(12):1870–81. doi: 10.1161/CIRCRESAHA.109.212746.
38.
CaiWJ, KocsisE, LuoX, SchaperW, SchaperJ. Expression of endothelial nitric oxide synthase in the vascular wall during arteriogenesis, Mol Cell Biochem. 2004;264(1-2):193–200. doi: 10.1023/b:mcbi.0000044388.27953.a0.
39.
ChengC, van HaperenR, de WaardM, van DammeLC, TempelD, HanemaaijerL, van CappellenGW, BosJ, SlagerCJ, DunckerDJ, van der SteenAF, de CromR, KramsR. Shear stress affects the intracellular distribution of eNOS: direct demonstration by a novel in vivo technique, Blood. 2005;106(12):3691–8. doi: 10.1182/blood-2005-06-2326.
40.
BagiZ, FrangosJA, YehJC, WhiteCR, KaleyG, KollerA. PECAM-1 mediates NO-dependent dilation of arterioles to high temporal gradients of shear stress, Arterioscler Thromb Vasc Biol. 2005;25(8):1590–5. doi: 10.1161/01.ATV.0000170136.71970.5f.
41.
ZicheM, MorbidelliL, ChoudhuriR, ZhangHT, DonniniS, GrangerHJ, BicknellR. Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis, J Clin Invest.-34. 1997;99(11):2625–34. doi: 10.1172/JCI119451.
42.
Schaper W. Collateral circulation: past and present, Basic Res Cardiol. 2009;104(1):5–21. doi: 10.1007/s00395-008-0760-x.
Bor-KüçükatayM, YalçinO, GökalpO, Kipmen-KorgunD, YesilkayaA, BaykalA, IspirM, SenturkUK, KaputluI, Başkurt OK. Red blood cell rheological alterations inhypertension induced by chronic inhibition of nitric oxide synthesisin rats, Clin Hemorheol Microcirc. 200022(4):267–75.
45.
SimmondsMJ, DetterichJA, ConnesP. Nitric oxide, vasodilation and the red blood cell, Biorheology. 2014;51(2-3):121–34. doi: 10.3233/BIR-140653.
46.
VarinR, MulderP, RichardV, TamionF, DevauxC, HenryJP, LallemandF, LereboursG, ThuillezC. Exercise improves flow-mediated vasodilatation of skeletal muscle arteries in rats with chronic heart failure, Role of nitric oxide, prostanoids, and oxidant stress. Circulation. 1999;99(22):2951–7. doi: 10.1161/01.cir.99.22.2951.
47.
BaskurtOK, YalcinO, OzdemS, ArmstrongJK, MeiselmanHJ. Modulation of endothelial nitric oxide synthase expression by red blood cell aggregation, Am J Physiol Heart Circ Physiol. -9. 2004Jan; 286(1):H222–9. doi: 10.1152/ajpheart.00532.2003.
48.
YalcinO, MeiselmanHJ, ArmstrongJK, BaskurtOK. Effect of enhanced red blood cell aggregation on blood flow resistance in an isolated-perfused guinea pig heart preparation, Biorheology. 2005;42(6):511–20.
